186 related articles for article (PubMed ID: 33651329)
1. Ultrasonographic technique to differentiate enhanced myometrial vascularity/arteriovenous malformation from retained products of conception.
Thakur M; Strug MR; De Paredes JG; Rambhatla A; Munoz MIC
J Ultrasound; 2022 Jun; 25(2):379-386. PubMed ID: 33651329
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations.
Timor-Tritsch IE; Haynes MC; Monteagudo A; Khatib N; Kovács S
Am J Obstet Gynecol; 2016 Jun; 214(6):731.e1-731.e10. PubMed ID: 26873276
[TBL] [Abstract][Full Text] [Related]
3. Use of hysteroscopy in diagnosis and follow-up of acquired uterine enhanced myometrial vascularity.
Gingold JA; Bradley LD
Fertil Steril; 2020 Feb; 113(2):460-462. PubMed ID: 32106997
[TBL] [Abstract][Full Text] [Related]
4. Enhanced myometrial vascularity: case presentation and review.
Woo J; Kahn B
Fertil Steril; 2021 Sep; 116(3):912-914. PubMed ID: 34217488
[TBL] [Abstract][Full Text] [Related]
5. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage.
Grewal K; Al-Memar M; Fourie H; Stalder C; Timmerman D; Bourne T
Ultrasound Obstet Gynecol; 2020 May; 55(5):676-682. PubMed ID: 31503383
[TBL] [Abstract][Full Text] [Related]
6. Clinical and ultrasonographic characteristics of pregnancy-related enhanced myometrial vascularity: prospective cohort study.
Xholli A; Scovazzi U; Londero AP; Paudice M; Vacca I; Schiaffino MG; Kratochwila C; Cavalli E; Perugi I; Cagnacci A;
Ultrasound Obstet Gynecol; 2024 May; 63(5):672-682. PubMed ID: 37984401
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of patients with enhanced myometrial vascularity associated with retained products of conception.
Groszmann YS; Healy Murphy AL; Benacerraf BR
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):396-399. PubMed ID: 29124818
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of women with radiologic findings suspicious for uterine arteriovenous malformations.
O'Rourke-Suchoff D; Benitez S; Higgins MCCS; Stier EA
J Obstet Gynaecol; 2021 Jul; 41(5):769-773. PubMed ID: 33054446
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound features help identify patients who can undergo noninvasive management for suspected retained products of conception: a single institutional experience.
Vyas S; Choi HH; Whetstone S; Jha P; Poder L; Shum DJ
Abdom Radiol (NY); 2021 Jun; 46(6):2729-2739. PubMed ID: 33459841
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-related uterine arteriovenous malformations: experience from a single medical center.
Vaknin Z; Sadeh-Mefpechkin D; Halperin R; Altshuler A; Amir P; Maymon R
Ultraschall Med; 2011 Dec; 32 Suppl 2():E92-9. PubMed ID: 21614746
[TBL] [Abstract][Full Text] [Related]
11. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception.
Van den Bosch T; Van Schoubroeck D; Timmerman D
J Ultrasound Med; 2015 Sep; 34(9):1577-82. PubMed ID: 26254150
[TBL] [Abstract][Full Text] [Related]
12. Retained products of conception mimicking a large endometrial AVM: complete resolution following spontaneous abortion.
Jain K; Fogata M
J Clin Ultrasound; 2007 Jan; 35(1):42-7. PubMed ID: 17024675
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic decision-making with transvaginal sonography for first trimester spontaneous abortion, clinically thought to be incomplete or complete.
Cetin A; Cetin M
Contraception; 1998 Jun; 57(6):393-7. PubMed ID: 9693399
[TBL] [Abstract][Full Text] [Related]
14. Extreme enhanced myometrial vascularity following cesarean scar pregnancy: a new diagnostic entity.
Timor-Tritsch IE; McDermott WM; Monteagudo A; Calί G; Kreines F; Hernandez S; Stephenson C; Bryk H; D'Antonio F
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5846-5857. PubMed ID: 33730990
[TBL] [Abstract][Full Text] [Related]
15. Enhanced myometrial vascularity and AVM: A review on diagnosis and management.
Moradi B; Banihashemian M; Sadighi N; Shirali E; Saleem SA; Najafi E
J Clin Ultrasound; 2023; 51(6):1051-1058. PubMed ID: 37285167
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Acquired Uterine Arteriovenous Malformation by Doppler Ultrasound.
Scribner D; Fraser R
J Emerg Med; 2016 Aug; 51(2):168-71. PubMed ID: 27260690
[TBL] [Abstract][Full Text] [Related]
17. Clinical and imaging predictors of management in retained products of conception.
Kamaya A; Krishnarao PM; Nayak N; Jeffrey RB; Maturen KE
Abdom Radiol (NY); 2016 Dec; 41(12):2429-2434. PubMed ID: 27853850
[TBL] [Abstract][Full Text] [Related]
18. HDlive Flow silhouette mode for the diagnosis of uterine enhanced myometrial vascularity/arteriovenous malformations.
Tenkumo C; Kanenishi K; AboEllail MAM; Yamamoto K; Ishibashi M; Mori N; Tanaka H; Hata T
J Med Ultrason (2001); 2018 Apr; 45(2):349-352. PubMed ID: 28840423
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous Resolution of an Acquired Uterine Arteriovenous Malformation in an Elderly Primigravida.
Ghizzoni V; Gabbrielli S; Mannini L; Sorbi F; Turrini I; Fantappiè G; Pavone D; Fambrini M; Noci I
Am J Case Rep; 2018 Sep; 19():1140-1145. PubMed ID: 30258044
[TBL] [Abstract][Full Text] [Related]
20. [Role of imaging in cases of bleeding after spontaneous or induced abortion].
Chassang M; Baudin G; Delotte J; Trastour C; Bongain A; Chevallier P
J Gynecol Obstet Biol Reprod (Paris); 2015 May; 44(5):398-402. PubMed ID: 25433565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
